Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?
Top Cited Papers
- 1 November 2004
- journal article
- review article
- Published by Elsevier in Trends in Cell Biology
- Vol. 14 (11) , 639-647
- https://doi.org/10.1016/j.tcb.2004.09.014
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA42978, CA63071, CA69577, GM65533)
This publication has 78 references indexed in Scilit:
- Comparative biology of mouse versus human cells: modelling human cancer in miceNature Reviews Cancer, 2003
- RASSF2 Is a Novel K-Ras-specific Effector and Potential Tumor SuppressorJournal of Biological Chemistry, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- The RASputin effect: Figure 1.Genes & Development, 2002
- RAF/RAS oncogenes and mismatch-repair statusNature, 2002
- Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumoursNature, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 AccumulationMolecular and Cellular Biology, 2002
- Ral GTPases Contribute to Regulation of Cyclin D1 through Activation of NF-κBMolecular and Cellular Biology, 2000
- Stimulation of Membrane Ruffling and MAP Kinase Activation by Distinct Effectors of RASScience, 1996